In this episode, Alicia Abella, AI Product Lead at Novo Nordisk, discusses how she is helping drive responsible AI adoption in the pharmaceutical industry. She shares her early experiences in AI, starting with her PhD research at Columbia University on image processing and natural language processing.
At Novo Nordisk, the current focus is on applying AI to commercialization functions including – marketing, legal, and HR – beyond its traditional use in drug discovery. Alicia highlights key use cases such as generative AI for knowledge search, content generation for marketing campaigns, and traditional AI techniques for deriving insights about healthcare providers. She also emphasizes the importance of applying a product mindset to AI development by evaluating user needs, business value, and compliance from the outset.
Alicia notes that adding effective governance can help innovation move in the right direction. She also talks about an internal AI Ambassador Program and emphasizes the importance of designing intuitive AI tools to increase adoption. She concludes by discussing future trends in AI, including contextual intelligence, user-centric design, and the opportunity for AI to enhance, rather than replace human decision-making. Take a listen.
In this episode, Dr. Roy Schoenberg, President and CEO of Amwell, discusses the current state of telehealth in the U.S. and how its adoption ...
In this episode, John Sculley discusses how there are opportunities for many companies in healthcare to innovate and disrupt. Unlike Facebook in social media...
The Big Unlock Podcast · From Automation to Autonomy: Agentic AI Is Healthcare’s Next Frontier-Episode 163-Shekar Ramanathan In this episode, Shekar Ramanathan, Executive...